Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement

Reuters03-31
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement

Overview

  • Canada dermatology firm's Q4 revenue fell yr/yr due to prior-year one-time reimbursement

  • Gross profit and margin rose, helped by higher-margin skincare sales and lower promotional costs

  • Company to be acquired by ClinActiv Holdings in all-cash deal at 74% premium, pending approvals

Outlook

  • Crescita expects acquisition by ClinActiv Holdings to close in Q2 2026

  • Company says economic uncertainty and softness in skincare market continue to impact operations

  • Crescita remains focused on operational execution while awaiting acquisition approvals

Result Drivers

  • PRIOR-YEAR ONE-TIME REIMBURSEMENT - Q4 revenue decline mainly due to $1.62 mln inventory reimbursement in Q4-2024 after amending agreement with largest manufacturing client

  • SKINCARE AND E-COMMERCE SALES - Higher Q4 skincare revenue, primarily from increased e-commerce sales and incremental revenue from Bacti Control acquisition, partly offset revenue decline

  • HIGHER OPERATING COSTS - Q4 operating expenses rose mainly due to increased advertising and promotion for digital sales, and higher regulatory, consulting and distribution fees

Company press release: ID:nBwT8Ll4a

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

C$5.96 mln

Q4 Adjusted EBITDA

C$70,000

Q4 Gross Margin

54.40%

Q4 Operating Expenses

C$3.62 mln

Q4 Operating Income

-C$381,000

Q4 Pretax Profit

-C$702,000

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment